Trial Profile
A multicenter, retrospective cohort study, efficacy and safety of Adjuvant Tigecycline in patients with Severe Clostridium difficile-Associated Diarrhea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary)
- Indications Clostridium difficile infections; Diarrhoea
- Focus Therapeutic Use
- 17 Dec 2015 New trial record